Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Breast Neoplasms 35Rectal Neoplasms 22Triple Negative Breast Neoplasms 16Stomach Neoplasms 16Colorectal Neoplasms 13Neoplasm Metastasis 9Adenocarcinoma 9Pancreatic Neoplasms 8Esophageal Neoplasms 8Adenocarcinoma Of Esophagus 7Neoplasms 5Nasopharyngeal Carcinoma 5Biliary Tract Neoplasms 5Parkinson Disease 4, Autosomal Dominant Lewy Body 4Carcinoma, Non-Small-Cell Lung 4Esophageal Squamous Cell Carcinoma 3Colonic Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Spinocerebellar Degenerations 2Ovarian Neoplasms 2Neoplasm, Residual 2Cholangiocarcinoma 2Carcinoma 2Anus Neoplasms 2Advanced Solid Tumour 2Somatostatinoma 1Solid Tumors 1Resectable Colon Cancer 1Rectal Cancer Patients 1Peritoneal Neoplasms 1

Interventions

Paclitaxel 6Mitomycin 3Carboplatin 3Bevacizumab 3sodium thiosulfate 2Laparoscopy 2Hyperthermic Intraperitoneal Chemotherapy 2Cisplatin 2relacorilant 1pembrolizumab 1oregovomab 1olaparib 1nilotinib 1liposomal doxorubicin 1Topotecan 1Taxes 1Standard of Care 1Specimen Handling 1Saline Solution 1Practice Guidelines as Topic 1Pancreatectomy 1Oxaliplatin 1Magnetic Resonance Spectroscopy 1Laparotomy 1Glucose 1Gemcitabine 1Fluorouracil 1Electrocardiography 1Doxorubicin 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Peritoneal Neoplasms × Capecitabine × 90 days × Clear all
NCT04034251 2026-05-05

Intraperitoneal and Intravenous Paclitaxel Chemotherapy With Oral Capecitabine for Gastric Adenocarcinoma With Peritoneal Carcinomatosis

National Institutes of Health Clinical Center (CC)

Phase 2 Terminated
12 enrolled 18 charts
GastrointestinalGynecologic

Adenocarcinoma, Peritoneal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡